The aetiology of pharyngotonsillitis in primary health care: a prospective observational study.
Group A streptococci
Pharyngotonsillitis
Predictive values
Primary health care
Symptoms
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
17 Sep 2021
17 Sep 2021
Historique:
received:
14
10
2020
accepted:
07
09
2021
entrez:
18
9
2021
pubmed:
19
9
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Few studies on pharyngotonsillitis have examined the clinical presentation of different aetiologies where pathogens have been detected using molecular methods. We aimed to assess how well clinical signs and symptoms can predict (1) the presence or absence of a broad range of viruses and bacteria, and (2) reconsultations for a sore throat or a complication. In this descriptive observational prospective study in primary health care 220 patients aged 15-45 with suspected pharyngotonsillitis were sampled from nose, throat and blood and screened for 20 bacteria and viruses using polymerase chain reaction (PCR), culture and serology. Odds ratios (OR) and predictive values with 95% confidence intervals (CI) were used to show association between microbiological findings and clinical signs and symptoms. Patients were followed up after 3 months by reviewing electronic medical records. Both cough and coryza were more common in patients with only viruses (67%) than in patients with only bacteria (21%) (p < 0.001), whereas tonsillar coating was more common in patients with only bacteria (53%) than in patients with only viruses (29%) (p = 0.006). Tonsillar coating (adjusted OR 6.0; 95% CI 2.5-14) and a lack of cough (adjusted OR 3.5; 95% CI 1.5-8.0) were significantly associated with Streptococcus pyogenes (group A streptococci; GAS) and with any bacterial finding. A Centor score of 3-4 had a positive predictive value of 49% (95% CI 42-57) for GAS and 66% (95% CI 57-74) for any bacterial findings. The use of rapid antigen detection test for GAS increased the positive predictive value for this group to 93%. Signs and symptoms, both single and combined, were insufficient to rule in GAS or other pathogens. However, both cough and coryza were useful to rule out GAS. The results support the clinical approach of restricting rapid antigen detection testing to patients with 3-4 Centor criteria. The low carriage rate of bacteria among asymptomatic controls implied that most detections in patients represented a true infection.
Sections du résumé
BACKGROUND
BACKGROUND
Few studies on pharyngotonsillitis have examined the clinical presentation of different aetiologies where pathogens have been detected using molecular methods. We aimed to assess how well clinical signs and symptoms can predict (1) the presence or absence of a broad range of viruses and bacteria, and (2) reconsultations for a sore throat or a complication.
METHODS
METHODS
In this descriptive observational prospective study in primary health care 220 patients aged 15-45 with suspected pharyngotonsillitis were sampled from nose, throat and blood and screened for 20 bacteria and viruses using polymerase chain reaction (PCR), culture and serology. Odds ratios (OR) and predictive values with 95% confidence intervals (CI) were used to show association between microbiological findings and clinical signs and symptoms. Patients were followed up after 3 months by reviewing electronic medical records.
RESULTS
RESULTS
Both cough and coryza were more common in patients with only viruses (67%) than in patients with only bacteria (21%) (p < 0.001), whereas tonsillar coating was more common in patients with only bacteria (53%) than in patients with only viruses (29%) (p = 0.006). Tonsillar coating (adjusted OR 6.0; 95% CI 2.5-14) and a lack of cough (adjusted OR 3.5; 95% CI 1.5-8.0) were significantly associated with Streptococcus pyogenes (group A streptococci; GAS) and with any bacterial finding. A Centor score of 3-4 had a positive predictive value of 49% (95% CI 42-57) for GAS and 66% (95% CI 57-74) for any bacterial findings. The use of rapid antigen detection test for GAS increased the positive predictive value for this group to 93%.
CONCLUSIONS
CONCLUSIONS
Signs and symptoms, both single and combined, were insufficient to rule in GAS or other pathogens. However, both cough and coryza were useful to rule out GAS. The results support the clinical approach of restricting rapid antigen detection testing to patients with 3-4 Centor criteria. The low carriage rate of bacteria among asymptomatic controls implied that most detections in patients represented a true infection.
Identifiants
pubmed: 34535115
doi: 10.1186/s12879-021-06665-9
pii: 10.1186/s12879-021-06665-9
pmc: PMC8446737
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
971Informations de copyright
© 2021. The Author(s).
Références
J Pediatr. 2012 Mar;160(3):487-493.e3
pubmed: 22048053
Br J Gen Pract. 2005 Aug;55(517):615-9
pubmed: 16105370
Clin Microbiol Infect. 2015 Mar;21(3):263.e1-7
pubmed: 25658556
Cochrane Database Syst Rev. 2016 Jul 04;7:CD010502
pubmed: 27374000
BMJ. 2000 Jan 15;320(7228):150-4
pubmed: 10634735
Ann Intern Med. 2015 Feb 17;162(4):241-7
pubmed: 25686164
BMJ Open. 2013 Mar 09;3(3):
pubmed: 23474784
Stat Med. 2007 May 10;26(10):2170-83
pubmed: 16927452
BMC Med. 2011 Jun 01;9:67
pubmed: 21631919
Scand J Infect Dis. 2002;34(12):880-6
pubmed: 12587619
BMJ. 2013 Oct 10;347:f5806
pubmed: 24114306
Clin Infect Dis. 2012 Nov 15;55(10):1279-82
pubmed: 23091044
BMC Infect Dis. 2018 Jan 2;18(1):3
pubmed: 29291704
PLoS One. 2012;7(6):e39085
pubmed: 22768060
Can Fam Physician. 2007 Apr;53(4):666-71
pubmed: 17872717
Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1903-1912
pubmed: 27568201
J Clin Microbiol. 2017 Apr;55(4):1147-1153
pubmed: 28122872
J Pediatr. 2019 Mar;206:268-273.e1
pubmed: 30528760
Pediatrics. 2010 Sep;126(3):e557-64
pubmed: 20696723
BMJ Open. 2013 Oct 25;3(10):e003943
pubmed: 24163209
J Antimicrob Chemother. 2017 Mar 1;72(3):914-922
pubmed: 27999063
Arch Intern Med. 2006 Mar 27;166(6):640-4
pubmed: 16567603
J Clin Virol. 2008 Jan;41(1):53-6
pubmed: 18093871
Med Decis Making. 1981;1(3):239-46
pubmed: 6763125
Pediatrics. 2007 Nov;120(5):950-7
pubmed: 17974731
Stat Med. 2002 Jun 30;21(12):1773-85
pubmed: 12111911
Arch Intern Med. 2012 Jun 11;172(11):847-52
pubmed: 22566485
Clin Infect Dis. 2010 Feb 15;50(4):481-90
pubmed: 20067422
BMJ. 2013 Nov 25;347:f6867
pubmed: 24277339
Pediatrics. 2010 Sep;126(3):e608-14
pubmed: 20696724
BMC Infect Dis. 2016 Nov 25;16(1):709
pubmed: 27887585
Br J Gen Pract. 2012 Nov;62(604):e787-94
pubmed: 23211183
Clin Microbiol Infect. 2012 Apr;18 Suppl 1:1-28
pubmed: 22432746